Default company panoramic image

Akrivis Technologies

Akrivis’ technology platform delivers ultrasensitive diagnostics and theranostics with high-resolution imaging and targeted therapies

  • Stage Prototype Ready
  • Industry Biotechnology
  • Location Cambridge, MA, USA
  • Currency EUR
  • Founded March 2009
  • Employees 4
  • Website

Company Summary

Akrivis is a privately held biotech company founded in 2009 in Cambridge, Massachusetts. Its patented ADAPT™ technology platform delivers a theranostic combination of ultrasensitive in vitro diagnostics, high-resolution imaging and targeted therapeutics. Akrivis, via a French entity, and the CEA-LETI in Grenoble are in final discussions to form a shared R&D laboratory in order to combine their respective ADAPT™ and Lipidot® technologies


  • Default avatar
    Christopher SCANNELL
    Chief Business Officer

  • Default avatar
    Joel BERNIAC
    President & CEO

  • Default avatar
    Ban-An KHAW
    Chief Scientific Officer